- Home
- / AstraZeneca
AstraZeneca
Stock Price
£111
2023-09-29
Market Capitalization
£184.2 B
2023-05-03
Revenue
$44.4 B
FY, 2022
AstraZeneca Summary
Company Summary
- Overview
- AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. It develops drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, gastroenterology, and other areas. The company offers its products to primary care and specialty care physicians.
- Type
- Public
- Status
- Active
- Founded
- 1999
- HQ
- Cambridge, GB | view all locations
- Website
- https://www.astrazeneca.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Johan Hyllner, Executive Director and Head of Cell Therapy, BioPharmaceuticals R&D
Hitesh Sanganee, Head of Emerging Innovations
Pam Cheng, Executive Vice-President, Operations, Information Technology and Sustainability
Operating MetricsView all
Healthcare Workers Trained
199K
50.5%
FY, 2021
New Phase I Projects
3
Q2, 2022
New Phase II Projects
1
75.0%
Q2, 2022
LocationsView all
109 locations detected
Cambridge, England HQ
United Kingdom
1 Francis Crick Ave
Coral Gables, FL
United States
804 Douglas Rd #630
Gaithersburg, MD
United States
1 Medimmune Way
Gaithersburg, MD
United States
200 Orchard Ridge Dr
Gaithersburg, MD
United States
950 Wind River Ln
Rockville, MD
United States
1700 Rockville Pike #250
AstraZeneca Financials
Summary Financials
- Revenue (Q2, 2023)
- $11.4B
- Gross profit (Q2, 2023)
- $11.5B
- Net income (Q2, 2023)
- $1.8B
- Cash (Q2, 2023)
- $5.7B
- EBIT (Q2, 2023)
- $2.5B
- Enterprise value
- $208.4B